Juan F. Rodriguez-Riascos MD , Hema Srikanth Vemulapalli MBBS , Padmapriya Muthu MBBS , Aria Raman BS , Poojan Prajapati MBBS , Shruti Iyengar MBBS, MSc , Sumedh Iyengar MD , Hicham El Masry MD , Arturo M. Valverde MD , Komandoor Srivathsan MD
{"title":"Post–pulmonary vein isolation voltage remapping–guided incremental lesions: A feasible strategy to improve long-term outcomes","authors":"Juan F. Rodriguez-Riascos MD , Hema Srikanth Vemulapalli MBBS , Padmapriya Muthu MBBS , Aria Raman BS , Poojan Prajapati MBBS , Shruti Iyengar MBBS, MSc , Sumedh Iyengar MD , Hicham El Masry MD , Arturo M. Valverde MD , Komandoor Srivathsan MD","doi":"10.1016/j.hroo.2024.12.015","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pulmonary vein isolation (PVI) has demonstrated acceptable success rates; however, there is still potential for improvement. Pulmonary reconnection remains the main problem and the role of adjunctive strategies, such as repeat mapping to guide additional lesions to enhance durability of pulmonary vein isolation, remains uncertain.</div></div><div><h3>Objective</h3><div>This study aimed to evaluate the impact of post-PVI high-density remapping with guided incremental lesions on long-term recurrence-free survival.</div></div><div><h3>Methods</h3><div>This study included consecutive patients who underwent PVI between 2015 and 2023. Patients were divided into 2 groups based on whether they received post-PVI high-density remapping. Those in the remapping group with documented areas of incomplete ablation received incremental lesions to achieve complete ablation. The primary endpoint was recurrence-free survival.</div></div><div><h3>Results</h3><div>A total of 588 patients, with a mean follow-up of 25.8 months, were included. Post-PVI remapping was performed in 243 patients, while 345 patients underwent conventional PVI. Post-PVI remapping with guided incremental lesions improved recurrence-free survival compared with conventional PVI (adjusted hazard ratio 0.75, 95% confidence interval [CI] 0.57-0.99, <em>P =</em> .04). This benefit was especially notable in patients with paroxysmal atrial fibrillation (hazard ratio 0.69, 95% CI 0.49-0.96, <em>P =</em> .027). Complication rates and procedure times were comparable between the 2 groups. For patients undergoing their first radiofrequency ablation, 1-year success was higher in those who underwent PVI remapping (adjusted odds ratio 1.70, 95% CI 1.04–2.77, <em>P =</em> .03). However, long-term outcomes were comparable between the 2 groups.</div></div><div><h3>Conclusion</h3><div>Postablation mapping effectively identifies and addresses proarrhythmic foci, potentially reducing atrial fibrillation recurrence and improving patient outcomes.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"6 4","pages":"Pages 424-433"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Rhythm O2","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266650182500008X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Pulmonary vein isolation (PVI) has demonstrated acceptable success rates; however, there is still potential for improvement. Pulmonary reconnection remains the main problem and the role of adjunctive strategies, such as repeat mapping to guide additional lesions to enhance durability of pulmonary vein isolation, remains uncertain.
Objective
This study aimed to evaluate the impact of post-PVI high-density remapping with guided incremental lesions on long-term recurrence-free survival.
Methods
This study included consecutive patients who underwent PVI between 2015 and 2023. Patients were divided into 2 groups based on whether they received post-PVI high-density remapping. Those in the remapping group with documented areas of incomplete ablation received incremental lesions to achieve complete ablation. The primary endpoint was recurrence-free survival.
Results
A total of 588 patients, with a mean follow-up of 25.8 months, were included. Post-PVI remapping was performed in 243 patients, while 345 patients underwent conventional PVI. Post-PVI remapping with guided incremental lesions improved recurrence-free survival compared with conventional PVI (adjusted hazard ratio 0.75, 95% confidence interval [CI] 0.57-0.99, P = .04). This benefit was especially notable in patients with paroxysmal atrial fibrillation (hazard ratio 0.69, 95% CI 0.49-0.96, P = .027). Complication rates and procedure times were comparable between the 2 groups. For patients undergoing their first radiofrequency ablation, 1-year success was higher in those who underwent PVI remapping (adjusted odds ratio 1.70, 95% CI 1.04–2.77, P = .03). However, long-term outcomes were comparable between the 2 groups.
Conclusion
Postablation mapping effectively identifies and addresses proarrhythmic foci, potentially reducing atrial fibrillation recurrence and improving patient outcomes.
背景:肺静脉隔离(PVI)已经证明了可接受的成功率;然而,仍有改进的潜力。肺重连仍然是主要问题,辅助策略的作用,如重复定位来指导额外的病变,以增强肺静脉隔离的持久性,仍然不确定。目的本研究旨在评估pvi后高密度重定位引导增量病变对长期无复发生存的影响。方法本研究纳入2015年至2023年间连续接受PVI的患者。根据患者是否接受pvi后高密度重测分为两组。重新定位组中记录有不完全消融区域的患者接受增量病灶以达到完全消融。主要终点是无复发生存期。结果共纳入588例患者,平均随访25.8个月。243例患者行PVI后重新定位,345例患者行常规PVI。与传统的PVI相比,PVI后重新定位与引导的增量病变改善了无复发生存率(校正风险比为0.75,95%可信区间[CI] 0.57-0.99, P = 0.04)。这种获益在阵发性心房颤动患者中尤为显著(风险比0.69,95% CI 0.49-0.96, P = 0.027)。两组间并发症发生率和手术时间具有可比性。对于首次接受射频消融的患者,接受PVI重新映射的患者1年的成功率更高(校正优势比1.70,95% CI 1.04-2.77, P = 0.03)。然而,两组之间的长期结果具有可比性。结论消融后定位能有效识别和定位心律失常灶,有可能减少房颤复发,改善患者预后。